Adaptyx Biosciences Presents First In-Human Continuous Multi-Day Free Cortisol Data From a Wearable Sensor at ADA, Providing a Time-resolved View of the Hormone Signal Driving Glucose Control, Cardiovascular Health, Stress Response, and Sleep
Adaptyx Biosciences, a Stanford University spinout commercializing more than 18 years of continuous molecular biosensing research, today presented the first continuous, multi-day measurement of free cortisol in humans at the American Diabetes Association's 86th Scientific Sessions. The data showed Adaptyx's wearable sensor measuring free cortisol from dermal interstitial fluid, the fluid just beneath the skin, in two first-in-human studies: a controlled oral hydrocortisone challenge in which the wearable signal tracked paired venous blood measurements, and overnight monitoring that captured the body's own cortisol rhythm during normal daily activity.
